Biochemical Markers of Alcohol Use and Their Clinical Aplications
Keywords:
Alcohol use, biochemical markers, clinical aplicationAbstract
Biochemical markers to detect excessive alcohol use are important for screening, treatment, and preventin of alcohol dependency and other alcohol-related medical diseases. These markers may also promote public health areas.In some countries, these markers are tested for identifying of heavy drinkers in occupational fields. To achieve these goals, biochemical markers must be characterized by several important features. These features include reliability, validity, stability, cost, practibility, acceptability, transportability. Unfortunately, to date, no single marker satisfies all these features. Traditional markers are low to moderate sensitivity, frequently false positives, poorly specified relationships with the amount of alcohol use. The most commonly used tests are gamma glutamyl transferase, alanine aminotransferase, aspartate aminotransferase, mean corpusculer volume and the newest marker, carbohydrate- deficient transferrin. Nowadays several new tests are under development. These include Early Detection of Alcohol Consumption Test, Hemoglobin Associated Acetaldehyde Assay and measures of fatty acid ethyl esters, and alcohol vapor at the skin surface. In his article, the literature of biochemical markers of alcohol use have been reviewed.
References
Grant BF, Harford TC, Dawson DA, et al. Prevalence of DSM-IV alcohol abuse and dependence. Alcohol Res Health 1994; 18: 243-248.
National Institute on Drug Abuse & National Institute on Alcohol Abuse and Alcoholism. The Economic Costs of Alcohol and Drug Abuse in the United States. Department of Health and Human Services. Bethesda, Maryland, 1998.
Dufour MC, Fe Caces M. Epidemiology of the medical consequences of alcohol. Alcohol Res Health 1993; 17: 265-271.
Bjerre B, Borg S, Helander A, et al. CDT a valuable marker of overconsumption of alcohol. Guidelines for its use in connection with automobile driver examination. Lakartidnin-gen 2001;14: 677-683.
Anton R, Moak DH, Latham P. Carbohydrate-deficient transferrin as an indicator of drinking status during a treatment outcome study. Alcohol Clin Exp Res 1996; 20: 841-846.
Mitchell C, Simpson D, Chick J. Carbohydrate-deficient transferin in detecting relapse in alcohol dependence. Drug Alcohol Depend 1997; 48:97-103.
Stibler H, Borg S. Carbohydrate composition of serum transferrin in alcoholic patients. Alcohol Clin Exp Res1986; 10: 61-64.
Ghosh P, Okoh C, Liu Q.-H, Lakshman MR. Effects of chronic ethanol on enzymes regulating sialylation and desialylation of transferrin in rats. Alcohol Clin Exp Res 1993; 17: 576-579
Xin Y, Lasker JM, Lieber CS. Serum carbohydrate- deficient transferrin: mechanism of increase after chronic alcohol intake. Hepatology 1995; 22:1462-1468.
Stibler H. Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin Chem 1991; 37:2029-2037.
Lesch OM, Walter H, Antal J, et al. Carbohydrate deficient transferin as a marker of alcohol intake: a study with healthy subjects. Alcohol Alcohol 1996; 31:265-271.
Litten RZ, Allen JP, Fertig JB. G-glutamyl-transpeptidase and carbohydrate-deficient transferin: alternative measures of excessive alcohol consumption. Clin Exp Res 1995; 19:1541-1546.
Sillanaukee P, Olsson U. Improved diagnostic classification of alcohol abusers by combining carbohydrate-deficient transferrin and gamma-glutamyl transferase. Clin Chem 2001; 47:681-685.
Glasinovic JC, Lobos X, Scrivanti M, et al. Carbohydrate-deficient transferrin, gammaglutamyl transferase and mean corpuscular volume in the evaluation of recent alcohol intake in excessive drinkers.Rev Med Chil 2001, 129: 375-381.
Mundle G, Munkes J, Ackermann K, et al. Sex differences of CDT, GGT and MCV in alcohol-dependent patients. Alcohol Clin Exp Res 2000; 24:1400-1405.
Huseby NE, Nilssen O, Erfurth A, et al. Carbohydrate-deficient transferrin and alcohol dependency: variation in response to alcohol intake among different groups patients. Alcohol Clin Exp Res 1997; 21: 201-205.
Schmidt LG, Schmidt K, Dufeu P, et al.; Superiority of carbohydrate-deficient transferrin to g-glutamyltransferase in detecting relapse in alcoholism. Am J Psychiatry 1997; 154: 75-80.
Anton RF, Dominick C, Bigelow M, Westby C. Comparison of bio-rad %CDT TIA and CDT as laboratory markers of heavy alcohol use and their relationships with gamma-glu-tamyltransferase. Clin Chem 2001; 47:17691775.
Stauber RE, Stepan V, Trauner M, et al. Evaluation of carbohydrate-deficient transferrin for detection of alcohol abuse in patients with liver dysfunction. Alcohol Alcohol 1995; 30: 171-176.
Murawaki Y, Sugisaki H, Yuasa I, Kawasaki H. Serum carbohydrate-deficient transferin in patients with nonalcoholic liver disease and with hepatocellular carcinoma. Clinica Chimica Acta 1997; 259: 97-108.
Javors MA, Pichot JT, King TS, Anton RF. Search for biological markers. Drug Addiction ant its Treatment. Johnson BA, Roache JD (Editörler). Philadelphia: Lippincott-Raven, 1997, s. 205-231.
Rosman AS, Lieber CS. Biochemical markers of alcohol consumption. Alcohol Health Res World 1990; 14: 208-218.
Gjerde H, Amundsen A, Skog OJ, et al. Serum gamma-glutamyltransferase: an epidemiological indicator of alcohol consumption? Br J Addict 1987; 82:1027-1031.
Salmela KS, Laitinen K, Nystrom M, Salas-puro M. Carbohydrate-deficient transferrin during 3 weeks heavy alcohol consumption. Alcohol Clin Exp Res1994; 18: 228-230.
Memesanszky E, Lott JA, Arato M. Changes in serum enzymes in moderate drinkers after and alcohol challenge. Clin Chem1998; 34: 525-527.
Salaspuro M. Conventional and coming laboratory markers of alcoholism and heavy drinking. Alcohol Clin Exp Res1986; 10(supl 6): 5-12.
Conigrave KM, Saunders JB, Whitfield JB. Diagnostic tests for alcohol consumption. Alcohol Alcohol 1995; 30:13-26.
Salaspuro M. Biological state markers of alcohol abuse. Alcohol Health Res World 1994; 18:131-139.
Whitfield JB. Gamma glutamyltransferase. Crit Rev Clin Lab Sci 2001; 38: 263-355.
Sharpe PC, McBride R, Archbold GPR.; Biochemical markers of alcohol abuse. QJM 1996; 89:137-144.
Allen JP, Litten RZ, Anton RF, Cross GM. Carbohydrate-deficient transferrin as a measure of immoderate drinking: remaining issues. Alcohol Clin Exp Res1994; 18: 799-812
Rubio M, Caballeria J, Deulofeu R, et al. Carbohydrate-deficient transferrin as a marker of alcohol consumption in male patients with liver disease. Alcohol Clin Exp Res 1997; 21: 923-927.
Mundle G, Munkes J, Ackermann K, et al. Sex differences of CDT, GGT and MCV in alcohol-dependent patients. Alcohol Clin Exp Res 2000; 24:1400-1405.
Mahuran D, Novak A, Lowden JA. The lysosomal hexosaminidase isoenyzmes. Isozymes Curr Top Biol Med Res 1985; 12: 229-288.
Hultberg B, Isaksson A, Berglund M, Moberg AL. Serum b-hexosaminidase isoenzyme: a sensitive marker for alcohol abuse. Alcohol Clin Exp Res 1991; 15: 549-552.
Stowell L, Stowell A, Garrett N, Robinson G. Comparison of serum b-hexosaminidase isoenzyme B activity with serum carbohydrate-deficient transferrin and other markers of alcohol abuse. Alcohol Alcohol1997; 32:703714.
Karkkainen P, Poikolainen K, Salaspuro M. Serum b-hexosaminidase as a marker of heavy drinking. Alcohol Clin Exp Res1990; 14: 187-190
Takeshita T, Morimoto K. Accumulation of HAA with habitual alcohol drinking in the atypical ALDH2 genotype. Alcohol Clin Exp Res 2000; 24:1-7.
Nomura F, Itoga S, Tamura M, et al. Biological markers of alcoholism with respect to genotypes of low-km aldehyde dehydrogenase (ALDH2) in Japanese subjects. Alcohol Clin Exp Res 2000; 24(Suppl 4):30-33.
Rosman AS, Waraich A, Baraona E, et al. Disulfiram treatment increases plasma and red blood cell acetaldehyde in abstinent alcoholics. Alcohol Clin Exp Res 2000; 24: 958964.
Harasymiw J, Vinson D, Bean P. The early detection of alcohol consumption score in the identification of heavy and at-risk drinkers from routine blood tests. J Addict Dis 2000; 19:43-59.
Meera V, Pal H, Sing R. Discriminative value of lipids and apolipoproteins in alcoholics. Prog Neuropsychopharmacol Biol Psychiatry 2001, 25:1011-22.
Wurst FM, Kempter C, Metzger J, et al. Ethyl glucuronide: a marker of recent alcohol consumption with clinical and forensic implications. Alcohol 2000; 20:111-116.
Auwarter V, Sporkert F, Hartwig S, et al. Fatty acid ethyl esters in hair as markers of alcohol consumption: segmental hair analysis of alcoholics, social drinkers, and teetotalers. Clin Chem 2001; 47:2114-2123.
Allen JP, Litten RZ. The role of laboratory tests in alcoholism treatment. J Subst Abuse Treat 2001; 20:87-88.
Allen JP, Litten RZ, Strid N, Sillanaukee P. The role of biomarkers in alcoholism medication trials. Alcohol Clin Exp Res 2001, 25: 1119-1125.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Dependence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
...